FR126M - New drug, in particular for the treatment of postprandial or chronic hyperlipemia. - Google Patents

New drug, in particular for the treatment of postprandial or chronic hyperlipemia.

Info

Publication number
FR126M
FR126M FR832448A FR832448A FR126M FR 126 M FR126 M FR 126M FR 832448 A FR832448 A FR 832448A FR 832448 A FR832448 A FR 832448A FR 126 M FR126 M FR 126M
Authority
FR
France
Prior art keywords
hyperlipemia
postprandial
chronic
treatment
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR832448A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR832448A priority Critical patent/FR126M/en
Application granted granted Critical
Publication of FR126M publication Critical patent/FR126M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR832448A 1960-06-21 1960-07-08 New drug, in particular for the treatment of postprandial or chronic hyperlipemia. Active FR126M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR832448A FR126M (en) 1960-06-21 1960-07-08 New drug, in particular for the treatment of postprandial or chronic hyperlipemia.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR830651A FR1363866A (en) 1960-06-21 1960-06-21 New heparin derivatives and method of preparation
FR832448A FR126M (en) 1960-06-21 1960-07-08 New drug, in particular for the treatment of postprandial or chronic hyperlipemia.

Publications (1)

Publication Number Publication Date
FR126M true FR126M (en) 1961-02-06

Family

ID=39273571

Family Applications (2)

Application Number Title Priority Date Filing Date
FR830651A Expired FR1363866A (en) 1960-06-21 1960-06-21 New heparin derivatives and method of preparation
FR832448A Active FR126M (en) 1960-06-21 1960-07-08 New drug, in particular for the treatment of postprandial or chronic hyperlipemia.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR830651A Expired FR1363866A (en) 1960-06-21 1960-06-21 New heparin derivatives and method of preparation

Country Status (3)

Country Link
US (1) US3232837A (en)
FR (2) FR1363866A (en)
GB (1) GB973894A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399824A (en) * 1971-08-16 1975-07-02 Mar Pha Etu Expl Marques Heparin esters
FR2482603A1 (en) * 1980-05-14 1981-11-20 Pharmindustrie NOVEL HEPARIN ESTERS FOR USE IN THE PREPARATION OF MEDICAMENTS, AND METHODS FOR THEIR PREPARATION
US4510135A (en) * 1982-04-21 1985-04-09 Research Corporation Orally administered heparin
US4654327A (en) * 1982-04-21 1987-03-31 Research Corp. Quaternary ammonium complexes of heparin
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2881161A (en) * 1955-03-25 1959-04-07 Henkel & Cie Gmbh Amides of alginic acid
US2954321A (en) * 1957-09-23 1960-09-27 Upjohn Co Process for preparing heparin
US2989438A (en) * 1958-12-29 1961-06-20 Roussel Uclaf Process of purifying heparin, and product produced therefrom

Also Published As

Publication number Publication date
FR1363866A (en) 1964-06-19
US3232837A (en) 1966-02-01
GB973894A (en) 1964-10-28

Similar Documents

Publication Publication Date Title
FR1593M (en) Compositions for the treatment of acne.
FR2713M (en) New drug in particular for the treatment of manifestations of hypoandrogenism, disorders of protein anabolism as well as for the treatment of hyperfolliculinia.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1009M (en) Medicine for the treatment of angina pectoris.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR36M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR1689M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1387M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1186M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1203M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR2148M (en) Topical composition for the treatment of warts.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
BE598665A (en) Pharmaceutical preparations for the treatment of leukemia.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.